|
[1]CUI X,CLARK DN,LIU K,et al.Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes[J].J Virol,2016,90(1):486-496.
|
|
[2]SATO S,LI K,KAMEYAMA T,et al.The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus[J].Immunity,2015,42(1):123-132.
|
|
[3]ZHANG X,MA Z,LIU H,et al.Role of Toll-like receptor 2 in the immune response against hepadnaviral infection[J].J Hepatol,2012,57(3):522-528.
|
|
[4]ISOGAWA M,ROBEK MD,FURUICHI Y,et al.Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J].J Virol,2005,79(11):7269-7272.
|
|
[5]WU J,LU M,MENG Z,et al.Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice[J].Hepatology,2007,46(6):1769-1778.
|
|
[6]WU J,HUANG S,ZHAO X,et al.Poly(I∶C)treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model[J].J Virol,2014,88(18):10421-10431.
|
|
[7]LAN P,ZHANG C,HAN Q,et al.Therapeutic recovery of hepatitis B virus(HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance[J].Hepatology,2013,58(1):73-85.
|
|
[8]LANFORD RE,GUERRA B,CHAVEZ D,et al.GS-9620,an oral agonist of Toll-like receptor-7,induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees[J].Gastroenterology,2013,144(7):1508-1517,1517.e1-e10.
|
|
[9]WU J,MENG Z,JIANG M,et al.Hepatitis B virus suppresses Toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells[J].Hepatology,2009,49(4):1132-1140.
|
|
[10]VISVANATHAN K,SKINNER NA,THOMPSON AJ,et al.Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein[J].Hepatology,2007,45(1):102-110.
|
|
[11]WANG S,CHEN Z,HU C,et al.Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation[J].J Immunol,2013,190(10):5142-5151.
|
|
[12]ZHENG M,SUN R,WEI H,et al.NK cells help induce antihepatitis B virus CD8+T cell immunity in mice[J].J Immunol,2016,196(10):4122-4131.
|
|
[13]REHERMANN B.Natural killer cells in viral hepatitis[J].Cell Mol Gastroenterol Hepatol,2015,1(6):578-588.
|
|
[14]PEPPA D,MICCO L,JAVAID A,et al.Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection[J].PLo S Pathog,2010,6(12):e1001227.
|
|
[15]PEPPA D,GILL US,REYNOLDS G,et al.Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion[J].J Exp Med,2013,210(1):99-114.
|
|
[16]KAKIMI K,GUIDOTTI LG,KOEZUKA Y,et al.Natural killer T cell activation inhibits hepatitis B virus replication in vivo[J].J Exp Med,2000,192(7):921-930.
|
|
[17]ITO H,ANDO K,ISHIKAWA T,et al.Role of Valpha14+NKT cells in the development of Hepatitis B virus-specific CTL:activation of Valpha14+NKT cells promotes the breakage of CTL tolerance[J].Int Immunol,2008,20(7):869-879.
|
|
[18]ZEISSIG S,MURATA K,SWEET L,et al.Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity[J].Nat Med,2012,18(7):1060-1068.
|
|
[19]JIANG X,ZHANG M,LAI Q,et al.Restored circulating invariant nkt cells are associated with viral control in patients with chronic hepatitis B[J].PLo S One,2011,6(12):69.
|
|
[20]OP den BROUW ML,BINDA RS,van ROOSMALEN MH,et al.Hepatitis B virus surface antigen impairs myeloid dendritic cell function:a possible immune escape mechanism of hepatitis B virus[J].Immunology,2009,126(2):280-289.
|
|
[21]CHEN L,ZHANG Z,CHEN W,et al.B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B[J].J Immunol,2007,178(10):6634-6641.
|
|
[22]ZHANG Z,CHEN D,YAO J,et al.Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B[J].Clin Immunol,2007,122(2):173-180.
|
|
[23]BILITY MT,CHENG L,ZHANG Z,et al.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:induction of human-specific liver fibrosis and M2-like macrophages[J].PLo S Pathog,2014,10(3):e1004032.
|
|
[24]XU L,YIN W,SUN R,et al.Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice[J].Hepatology,2014,59(2):443-452.
|
|
[25]LI M,SUN R,XU L,et al.Kupffer cells support hepatitis B virus-mediated CD8+T cell exhaustion via hepatitis B core antigenTLR2 interactions in mice[J].J Immunol,2015,195(7):3100-3109.
|
|
[26]TIAN Y,KUO CF,AKBARI O,et al.Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission[J].Immunity,2016,44(5):1204-1214.
|
|
[27]THIMME R,WIELAND S,STEIGER C,et al.CD8+T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection[J].J Virol,2003,77(1):68-76.
|
|
[28]REHERMANN B,FERRARI C,PASQUINELLI C,et al.The hepatitis B virus persists for decades after patients'recovery from acute viral hepatitis despite active maintenance of a cytotoxic Tlymphocyte response[J].Nat Med,1996,2(10):1104-1108.
|
|
[29]GUIDOTTI LG,INVERSO D,SIRONI L,et al.Immunosurveillance of the liver by intravascular effector CD8(+)T cells[J].Cell,2015,161(3):486-500.
|
|
[30]BONI C,PENNA A,OGG GS,et al.Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B:new perspectives for immune therapy[J].Hepatology,2001,33(4):963-971.
|
|
[31]NEBBIA G,PEPPA D,SCHURICH A,et al.Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection[J].PLo S One,2012,7(10):e47648.
|
|
[32]SCHURICH A,KHANNA P,LOPES AR,et al.Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosisprone CD8 T cells in persistent hepatitis B virus infection[J].Hepatology,2011,53(5):1494-1503.
|
|
[33]BENGSCH B,MARTIN B,THIMME R.Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation[J].J Hepatol,2014,61(6):1212-1219.
|
|
[34]RAZIORROUH B,SCHRAUT W,GERLACH T,et al.The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+T-cell function[J].Hepatology,2010,52(6):1934-1947.
|
|
[35]LIU J,ZHANG E,MA Z,et al.Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-l1 blockade in chronic hepadnaviral infection[J].PLo S Pathog,2013,58(1):e1003856.
|
|
[36]PALLETT LJ,GILL US,QUAGLIA A,et al.Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells[J].Nat Med,2015,21(6):591-600.
|
|
[37]ASABE S,WIELAND SF,CHATTOPADHYAY PK,et al.The size of the viral inoculum contributes to the outcome of hepatitis B virus infection[J].J Virol,2009,83(19):9652-9662.
|
|
[38]FRANCO A,GUIDOTTI LG,HOBBS MV,et al.Pathogenetic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice[J].J Immunol,1997,159(4):2001-2008.
|
|
[39]PENNA A,FOWLER P,BERTOLETTI A,et al.Hepatitis B virus(HBV)-specific cytotoxic T-cell(CTL)response in humans:characterization of HLA classⅡ-restricted CTLs that recognize endogenously synthesized HBV envelope antigens[J].J Virol,1992,66(2):1193-1198.
|
|
[40]ZENG Z,LI L,CHEN Y,et al.Interferon-gamma facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance[J].J Exp Med,2016,213(6):1079-1093.
|
|
[41]DIETZE KK,SCHIMMER S,KRETZMER F,et al.Characterization of the treg response in the hepatitis B virus hydrodynamic injection mouse model[J].PLo S One,2016,11(3):e0151717.
|
|
[42]YANG B,WANG Y,ZHAO C,et al.Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection[J].Immunol Lett,2013,149(1-2):41-49.
|
|
[43]PUBLICOVER J,GOODSELL A,NISHIMURA S,et al.IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B[J].J Clin Invest,2011,121(3):1154-1162.
|
|
[44]LI Y,MA S,TANG L,et al.Circulating chemokine(C-X-C Motif)receptor 5(+)CD4(+)T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection[J].Hepatology,2013,8(4):1277-1286.
|
|
[45]XU L,YIN W,SUN R,et al.Liver type I regulatory T cells suppress germinal center formation in HBV-tolerant mice[J].Proc Natl Acad Sci U S A,2013,110(42):16993-16998.
|
|
[46]YAN H,ZHONG G,XU G,et al.Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus[J].Elife,2012,3(1):e00049.
|
|
[47]ZHANG TY,YUAN Q,ZHAO JH,et al.Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen[J].Gut,2016,65(4):658-671.
|
|
[48]OLIVIERO B,CERINO A,VARCHETTA S,et al.Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections[J].J Hepatol,2011,55(1):53-60.
|
|
[49]DAS A,ELLIS G,PALLANT C,et al.IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection[J].J Immunol,2012,189(8):3925-3935.
|
DownLoad: